...protein that the spike binds to mediate viral cell invasion. Sorrento gained exclusive rights from Mabpharm Ltd....

...subsidiaries’ clinical programs. Development, manufacturing deals Sorrento Therapeutics Inc. (NASDAQ:SRNE) has gained exclusive rights from Mabpharm Ltd....
...ns2) Moderna Therapeutics Inc. U.S. Department of Defense American Society of Clinical Oncology Ampio Pharmaceuticals Inc. BridgeBio Pharma Inc. Sorrento Therapeutics Inc. Mabpharm Ltd. Inovio...

...The chapter's other 2019 listings included CStone Pharmaceuticals Co. Ltd. (HKEX:2616), CanSino Biologics Inc. (HKEX:6185), Mabpharm Ltd....

...it would wait for better market conditions before moving forward with its application. In May, Mabpharm Ltd....

...6/5/19 $13.6 $70.6 $70.1 -1% Taiwan Biomaterial Co. Ltd. (TPEx:6649) 6/5/19 $3.7 $44.1 $43.1 -2% Mabpharm Ltd....

...Mabpharm down in first day of Hong Kong trading Mabpharm Ltd. (HKSE:2181) lost HK$0.29 to HK$1.21 in...
...the U.S. and is in Phase Ib testing in China. Brian Moy, Assistant Editor DTRM-12, DTRMWXHS-12 Amicus Therapeutics Inc. Mabpharm Ltd. Myovant...

...Raises $85 Million in Series E Round” ). Mabpharm sets terms for Hong Kong IPO Mabpharm Ltd....
...Pfizer Ventures, Taiho Ventures and IP Group in the round. Hongjiang Li, Staff Writer RI-002 ADMA Biologics Inc. DNA Script Mabpharm Ltd. Schroedinger...

...Up to $75M Ph II Hansoh Pharmaceutical Group Co. Ltd. (HKEX) 9/6/18 TBD Mkt (drug) Mabpharm Ltd....

...amid a vaccine scandal and a trade war with the U.S. (see "Vaccine Volatility" ). Mabpharm Ltd....